
John Vanchiere
Chief Strategic Health Initiatives Officer · LSU Health Sciences Center
Credentials: · · · ·
History
- Present
Clinical Trials Office · LSU Health Sciences Center
- Present
- 1999–2002
Pediatric Infectious Diseases
- 1996–1999
Pediatrics
- 1992–1996
Doctor of Medicine
Research
Valganciclovir for symptomatic congenital cytomegalovirus disease
New England Journal of Medicine · 2015 · 588 citations
Virology · 1994 · 101 citations
medRxiv · 2021 · 88 citations

23 papers

7 papers
- AA
6 papers · 6 as a resident

4 papers

3 papers
- JB
3 papers · 1 as a resident

3 papers

3 papers
Grants
- 2016–2019
Development of a Nonhuman Primate Model of Polyomavirus Disease
NIH Office of the Director · R24
Contact PI · $1.8M · Louisiana State Univ Hsc Shreveport
- 2009–2012
COBRE Center for Molecular and Tumor Virology
National Center for Research Resources · P20
Project lead · $631K · Louisiana State Univ Hsc Shreveport
- 2002–2007
The Role of Polyomaviruses in Pediatric Renal Diseases
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $602.6K · Baylor College of Medicine
Clinical trials
- 2015–2020
Principal investigator · Completed · Phase 3
BioCryst Pharmaceuticals

